title: How should we balance individual and population benefits of statins for preventing cardiovascular disease?
authors.affiliation: Genetic Epidemiology Group, Department of Epidemiology and Public Health, University College London, London WC1E 6BT, UK. a.hingorani@ucl.ac.uk
authors.forename: Aroon D
authors.initials: AD
authors.lastname: Hingorani
authors.forename: Harry
authors.initials: H
authors.lastname: Hemingway
mesh_terms: D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000191:economics; D016527:Drug Costs; D016568:Drugs, Generic / Q000627:therapeutic use; D006291:Health Policy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D018570:Risk Assessment
chemical_list: D016568:Drugs, Generic; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors